A phase II trial of neoadjuvant imatinib for large gastric GIST in Japan and Korea
Not Applicable
- Conditions
- Gastrointestinal Stromal Tumor (GIST)
- Registration Number
- JPRN-UMIN000003114
- Lead Sponsor
- Japanese Study Group on GIST
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who have a medical history of active double cancers in the past 5 years 2)Patients who have a medical history of GIST 3)Patients who have heart disease of NYHA (New York Heart Association) class III or IV 4)Patients who are pregnant, lactating, or with the intention of becoming pregnant (including men) 5)Patients who have uncontrollable diseases or serious complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method